Search
Vitamin A
go.drugbank.com/drugs/DB00162ApprovedInvestigationalNutraceuticalVet approvedRetinol and derivatives of retinol that play an essential role in metabolic functioning of the retina, the growth of and differentiation of epithelial tissue, the growth of bone, reproduction, and the immune response. Dietary vitamin A i...
Synonyms: (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-olMixtures: COLEDAN-A 200.000IU/10 ML+100.000 IU/10 ML ORAL DAMLA, ÇÖZELTİ, 10 ML, DESİFEROL PLUS 2000 IU+3333 IU+70 MG/ML ORAL DAMLA, 30 MLMoxifloxacin
go.drugbank.com/drugs/DB00218ApprovedInvestigationalBayer AG developed the drug (initially called BAY 12-8039) and it is marketed worldwide (as the hydrochloride) under the brand name Avelox (in some countries also Avalox) for oral treatment.
Mixtures: Ixoba M, MOXİDEXA % 0,5 + % 0,1 GÖZ DAMLASI, ÇÖZELTİ, 1 ADETSynonyms: 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4as,7as)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acidChloroprocaine
go.drugbank.com/drugs/DB01161ApprovedInvestigationalBoth can be given as intrathecal injections for peripheral and central nerve block, but only the preservative-free formulation can be used for lumbar and caudal epidural blocks. … [A252952,L43382] Topical chloroprocaine for ophthalmic use was approved by the FDA in September 2022 for ocular surface anesthesia.[L43387]
Products: Ampres 10 mg/ml Injektionslösung, Ampres 20 mg/ml InjektionslösungTigecycline
go.drugbank.com/drugs/DB00560ApprovedInvestigationalIt was granted fast-track approval by the U.S. Food and Drug Administration (FDA) on June 17, 2005. … Tigecycline is a glycylcycline antibiotic developed and marketed by Wyeth under the brand name Tygacil.
Products: TİGENEX 50 MG İNFÜZYONLUK ÇÖZELTİ İÇİN TOZ, 10 FLAKON, TYGEPOL 50 MG I.V. İNFÜZYONLUK ÇÖZELTİ İÇİN LİYOFİLİZE TOZ, 10 ADETGuaifenesin
go.drugbank.com/drugs/DB00874ApprovedInvestigationalVet approvedGuaifenesin possesses a storied history, having been originally formally approved by the US FDA in 1952 and continues to be one of very few - if not perhaps the only drug that is readily available and … After the negotiation between FDA and major manufacturers, a voluntary transition of labels for not using guaifenesin in children under the age of 4 years was endorsed by FDA in 2008 [F4525].
Mixtures: SUDAFED EKSPEKTORAN 30 MG+100 MG/5 ML ŞURUP, 150 ML, BROKSIN 6.66 MG/5 ML+100 MG/5 ML SURUP, 150 MLInternational brands: Duratuss GSotalol
go.drugbank.com/drugs/DB00489ApprovedInvestigational[A178579] Sotalol was first approved as an oral tablet on 30 October 1992.
Synonyms: 4'-(1-hydroxy-2-(isopropylamino)ethyl)methane sulfonanilideProducts: SOTALEX 160 MG, PMS-sotalol - 160 mgVecuronium
go.drugbank.com/drugs/DB01339ApprovedInvestigationalMonoquaternary homolog of pancuronium. A non-depolarizing neuromuscular blocking agent with shorter duration of action than pancuronium. Its lack of significant cardiovascular effects and lack of dependence on good kidney function for el...
Products: NORCURON 10 MG, BROMURODE VECURONIO 10 MGIodide I-131
go.drugbank.com/drugs/DB09293ApprovedInvestigationalAs a result of beta decay, approximately 10% of its energy and radiation dose is via gamma radiation, while the other 90% (beta radiation) causes tissue damage without contributing to any ability to see
Products: MON.IYOT-131 0.37-7400 MBQ (10µ Cİ-200 M Cİ) ORAL KAPSÜL, 10 MCİ, MON.IYOT-131 74-18500 MBQ ORAL ÇÖZELTİ İÇEREN FLAKON, 10 MCİDicyclomine
go.drugbank.com/drugs/DB00804ApprovedInvestigational[L7982] Dicyclomine was granted FDA approval on 11 May 1950.[L7967] … Dicyclomine is a muscarinic M1, M3, and M2 receptor antagonist as well as a non-competitive inhibitor of histamine and bradykinin used to treat spasms of the intestines seen in functional bowel disorder
Synonyms: 2-(diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate, Bicyclohexyl-1-carboxylic acid 2-diethylamino-ethyl esterProducts: RELESTAL PEDIATRIC SYRUP 10 mg/5 ml, Bentylol Inj 10mg/mlGadoteric acid
go.drugbank.com/drugs/DB09132ApprovedInvestigational[A263141,A263106] Gadoterate is approved by the FDA under the brand name DOTAREM on 20th March 2013 for intravenous uses with magnetic resonance imaging (MRI) in the brain (intracranial), spine, and
Synonyms: [2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl-κ4N1,N4,N7,N10)tetraacetato(3−)]gadoliniumProducts: CLARİSCAN 0.5 MMOL/ML ENJEKSİYONLUK ÇÖZELTİ, 10 ML, DOTAREM 0,5 MMOL/ML ENJEKSİYONLUK ÇÖZELTİ İÇEREN FLAKON, 10 ML